BACKGROUND: It has been hypothesized that patients who are super-super morbidly obese, defined as having a body mass index (BMI) of 60 kg/m(2) or higher, have an increased rate of postoperative complications. As surgical techniques and operator experience with Roux-en-Y gastric bypass improved with time, the selection criteria have expanded to include the super-super morbidly obese. We hypothesize that a higher BMI does not predict a higher postoperative complication rate. METHODS: The prospectively collected database for our Accredited Bariatric Program was queried for all laparoscopic Roux-en-Y gastric bypass procedures performed between January 2004 and July 2006. All cases were performed by a single surgeon at a tertiary-care center. Average postoperative follow-up time was 1 year. Patients were stratified into two groups: BMI < 60 kg/m(2) and BMI >or= 60 kg/m(2). The number of postoperative complications was compared between the two groups using a chi-square method with Yates correction. RESULTS: One hundred and sixty-nine patients with adequate follow-up data were identified during the study period. Of these, 148 patients had BMI < 60 kg/m(2) (group 1) and 21 had BMI >or= 60 kg/m(2) (group 2). There were 28 (19%) total complications in group 1, and 4 (19%) total complications in group 2. There was no statistical difference between the two groups (p = 0.98). Stricture rate was 10% in group 1 and 5% in group 2. CONCLUSION: Patients with BMI >or= 60 kg/m(2) do not have a higher postoperative morbidity compared with other patients undergoing laparoscopic Roux-en-Y gastric bypass. The stricture rate is less in patients with BMI >or= 60 kg/m(2) compared with other patients. Longer follow-up is required to detect complications that occur after 1 year. Our study shows that laparoscopic Roux-en-Y gastric bypass can be safely performed on the super-supermorbidly obese.
BACKGROUND: It has been hypothesized that patients who are super-super morbidly obese, defined as having a body mass index (BMI) of 60 kg/m(2) or higher, have an increased rate of postoperative complications. As surgical techniques and operator experience with Roux-en-Y gastric bypass improved with time, the selection criteria have expanded to include the super-super morbidly obese. We hypothesize that a higher BMI does not predict a higher postoperative complication rate. METHODS: The prospectively collected database for our Accredited Bariatric Program was queried for all laparoscopic Roux-en-Y gastric bypass procedures performed between January 2004 and July 2006. All cases were performed by a single surgeon at a tertiary-care center. Average postoperative follow-up time was 1 year. Patients were stratified into two groups: BMI < 60 kg/m(2) and BMI >or= 60 kg/m(2). The number of postoperative complications was compared between the two groups using a chi-square method with Yates correction. RESULTS: One hundred and sixty-nine patients with adequate follow-up data were identified during the study period. Of these, 148 patients had BMI < 60 kg/m(2) (group 1) and 21 had BMI >or= 60 kg/m(2) (group 2). There were 28 (19%) total complications in group 1, and 4 (19%) total complications in group 2. There was no statistical difference between the two groups (p = 0.98). Stricture rate was 10% in group 1 and 5% in group 2. CONCLUSION:Patients with BMI >or= 60 kg/m(2) do not have a higher postoperative morbidity compared with other patients undergoing laparoscopic Roux-en-Y gastric bypass. The stricture rate is less in patients with BMI >or= 60 kg/m(2) compared with other patients. Longer follow-up is required to detect complications that occur after 1 year. Our study shows that laparoscopic Roux-en-Y gastric bypass can be safely performed on the super-supermorbidly obese.
Authors: D S Tichansky; E J DeMaria; A Z Fernandez; J M Kellum; L G Wolfe; J G Meador; H J Sugerman Journal: Surg Endosc Date: 2005-05-05 Impact factor: 4.584
Authors: Raquel Sánchez-Santos; Nuria Vilarrasa; Jorge Pujol; Pablo Moreno; Jose Manuel Francos; Antonio Rafecas; Carlos Masdevall Journal: Obes Surg Date: 2006-04 Impact factor: 4.129
Authors: Anna Duprée; Alexander Tarek El Gammal; Stefan Wolter; Silvana Urbanek; Nina Sauer; Oliver Mann; Philipp Busch Journal: Obes Surg Date: 2018-07 Impact factor: 4.129
Authors: Carlos Zerrweck; Elisa M Sepúlveda; Hernán G Maydón; Francisco Campos; Antonio G Spaventa; Verónica Pratti; Itzel Fernández Journal: Obes Surg Date: 2014-05 Impact factor: 4.129
Authors: Hassan Nasser; Tommy Ivanics; Oliver A Varban; Jonathan F Finks; Aaron Bonham; Amir A Ghaferi; Arthur M Carlin Journal: Surg Endosc Date: 2020-06-22 Impact factor: 4.584
Authors: Carlos Zerrweck; Vincent Maunoury; Robert Caiazzo; Julien Branche; Guélareh Dezfoulian; Philippe Bulois; Helene Verkindt; Marie Pigeyre; Laurent Arnalsteen; François Pattou Journal: Obes Surg Date: 2012-05 Impact factor: 4.129
Authors: Oscar K Serrano; Jonathan E Tannebaum; Lindsay Cumella; Jenny Choi; Pratibha Vemulapalli; W Scott Melvin; Diego R Camacho Journal: Surg Endosc Date: 2015-08-25 Impact factor: 4.584
Authors: Raelina S Howell; Helen H Liu; Harika Boinpally; Meredith Akerman; Elizabeth Carruthers; Barbara M Brathwaite; Patrizio Petrone; Collin E M Brathwaite Journal: JSLS Date: 2021 Apr-Jun Impact factor: 2.172